Senior Leadership

高层领导

• 批准号: 8695837
• 负责人: Andrew S Kraft
• 金额: $ 27.46万
• 依托单位: MEDICAL UNIVERSITY OF SOUTH CAROLINA
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2019-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8695837
• 关键词: Area; Basic Science; Cancer Burden; Cancer Center; Cancer Center Support Grant; Cancer Control; Charge; Clinical; Clinical Services; Clinical Trials; Commit; Communities; Consensus; Counseling; Doctor of Philosophy; Elements; Ensure; Evaluation; Feedback; Gap Junctions; Goals; Growth; Instruction; Leadership; Medical; Mission; National Cancer Institute; Patient Care; Physician Executives; Prevention program; Professional Education; Recommendation; Research; Resource Allocation; Resource Sharing; Resources; South Carolina; Strategic Planning; Techniques; Training and Education; Translational Research; Underserved Population; Universities; Vision; Work; authority; base; cancer health disparity; cancer prevention; innovation; meetings; outreach; programs; rapid growth; research and development; success

PROJ ECT SU M MARY (See Instructions): The Hollings Cancer Center (HCC) is directed by Andrew S. Kraft, MD with the assistance of a senior leadership team, and together they represent the strong functional nexus of this matrix-based Center. The team is comprised of eight associate directors, each of whom has outstanding expertise in their area of responsibility. They are: Anthony J. Alberg, PhD, MPH, Associate Director of Cancer Control; Marvella E. Ford, PhD, Associate Director of Cancer Disparities; Anita L. Harrison, MPA, Associate Director of Administration; Philip H. Howe, PhD, Associate Director of Basic Sciences; Michael B. Lilly, MD, Associate Director of Translational Research; Steven A. Rosenzweig, PhD, Associate Director of Shared Resources; Melanie B. Thomas, MD, Associate Director of Clinical Investigations; Dennis K. Watson, PhD, Associate Director of Education & Training; and Kevin F. Staveley-O'Carroll, MD, PhD, Medical Director of the HCC Clinical Service Line. The HCC senior leadership team meets once a month as a formal Executive Council, one-on-one with the Director at least monthly, and more frequently with each other and the Director in the context of various HCC board/committee meetings. They provide direct counsel and recommendations to the Director based on these interactions. All final authority for decisions on behalf of the HCC resides with the Director. Dr. Kraft has charged the senior leadership with employing consensus-building techniques as they work directly with the program leaders, shared resource directors, and various HCC boards and committees in formulating center-wide priorities, strategies, and allocation of resources. They work together as a team to ensure consistency in the mission, vision, and goals of the Center and develop synergistic interactions among the basic, translational, and clinical elements of the Center. They provide feedback on the growth of the HCC in their area of responsibility, which is particularly important given the rapid growth of the HCC, and evolving research directions at the national level. Based on this, they plan and implement proactive, integrative approaches for development of the research base, resources, and a formal strategic plan. The consistency of vision is particularly important in effectively leveraging all available resources at MUSC and at the state and national levels and engagement of the community in outreach activities.

Proj ect su Mary（请参阅说明）： Hollings癌症中心（HCC）由医学博士Andrew S. Kraft在高级领导团队的协助下执导，它们共同代表了这个基于矩阵的中心的强大功能联系。该团队由八名副董事组成，每个董事在其责任领域都有出色的专业知识。他们是：Anthony J. Alberg博士，MPH，癌症控制副总监； Marvella E. Ford博士，癌症差异副主任；管理行政副主任MPA Anita L. Harrison；菲利普·H·豪（Philip H. Howe）博士，基础科学副主任；迈克尔·B·莉莉（Michael B. Lilly）医学博士，转化研究副总监；共享资源副总监Steven A. Rosenzweig博士；临床研究副主任Melanie B. Thomas医学博士；教育与培训副总监Dennis K. Watson博士； HCC临床服务系列医学总监Kevin F. Staveley-O'Carroll医学博士。 HCC高级领导团队每月举行一次正式执行委员会开会，至少每月与董事一对一，在各种HCC董事会/委员会会议的背景下，彼此之间和董事更频繁。他们根据这些互动向董事提供直接的律师和建议。代表HCC决定的所有最终决定权与董事有关。 Kraft博士指控高级领导人在直接与计划负责人，共享资源总监以及各种HCC董事会和委员会合作时采用共识建设技术，以制定中央范围的优先事项，策略和资源分配。他们共同努力，以确保中心的任务，愿景和目标的一致性，并在中心的基本，翻译和临床元素之间发展协同互动。他们提供了有关HCC在其责任领域增长的反馈，鉴于HCC的迅速增长以及在国家一级不断发展的研究方向，这一点尤其重要。基于这一点，他们计划并实施积极主动的综合方法，以开发研究基础，资源和正式战略计划。愿景的一致性在有效利用MUSC以及州和国家层面以及社区参与外展活动的所有可用资源方面尤为重要。